CyTIX-01

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCyTIX-01

Drug Alias NameCyTIX-01

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsGlioma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCell-Therapy Technology Institute

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCell-Therapy Technology Institute

Active IndicationsN/A

Inactive IndicationsGlioma

Other Information

ATC CodeN/A